Technology

Ascendian Healthcare Consulting has announced a comprehensive vendor neutral archive (VNA) acceleration solution that enables healthcare organizations rapid accessibility, efficiency and shared utilization of medical imaging assets.

Home August 30, 2013
Home
Technology

August 30, 2013 — PFM Medical received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its Nit-Occlud Patent Ductus Arteriosus (PDA) device, a permanently implanted prosthesis indicated for percutaneous, transcatheter closure of small to moderate size patent ductus arteriosus.

Home August 30, 2013
Home
Technology

Philips Healthcare launched the Epiq ultrasound system, a first-of-its-kind ultrasound architecture that offers a new approach to creating ultrasound images. Making its debut at the European Society of Cardiology (ESC) 2013 Congress in Amsterdam, Epiq features a new imaging technology called nSIGHT that, when combined with Philips' new Anatomical Intelligence technology, delivers faster speed and improved image clarity. It has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Home August 30, 2013
Home
Diagnosing Pericardial Disease Using Multi-modality Imaging Protocols
Feature

To counter the significant levels of morbidity and mortality associated with pericardial disease (disease of the sac around the heart), experts from the American Society of Echocardiography (ASE), the Society for Cardiovascular Magnetic Resonance (SCMR), and the Society of Cardiovascular Computed Tomography (SCCT) came together to review evidence and provide future guidance to clinicians. For the first time, an expert consensus statement on the appropriate use of multimodality imaging in the diagnosis and management of pericardial diseases will be published in the September issue of the Journal of the American Society of Echocardiography (JASE). The writing group was chaired by Allan L. Klein, M.D., FASE, director of Cardiovascular Imaging Research and the Pericardial Center and an echocardiographer from the esteemed Cleveland Clinic in Cleveland, Ohio.

Home August 30, 2013
Home
News

Digirad Corp. and Dilon Diagnostics have signed an exclusive international distribution agreement for Dilon to distribute Digirad's lines of nuclear imaging cameras. .

Home August 30, 2013
Home
Technology

Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has cleared two new Jetstream atherectomy catheters. The SC (Single Cutter) atherectomy catheter is available in 1.6-mm and 1.85-mm cutting diameters. The XC (eXpandable cutter) atherectomy catheter features both front cutting tip and expandable blade technology for use in larger vessels. The XC is available in two cutting diameters: 2.1-mm blades down / 3.0-mm blades up and 2.4-mm blades down / 3.4-mm blades up.

Home August 29, 2013
Home
Feature

August 28, 2013 — Effective Oct. 1, Cook Medical’s Zilver PTX drug-eluting peripheral stent qualifies for new-technology add-on payments under Medicare’s hospital inpatient prospective payment system.

Home August 28, 2013
Home
News

According to Millennium Research Group (MRG), efforts to streamline the regulatory approval process in Japan have resulted in the recent entry of numerous devices in the Japanese peripheral vascular (PV) device market, and more products, such as drug-coated balloons and infrapopliteal stents, are expected to enter in the next few years.

Home August 28, 2013
Home
Feature

Experts have found that radiation dosage can have serious complications for patients with cancer. Cancer patients who receive chest radiation should be evaluated for heart disease before beginning radiation, and every five to 10 years afterward, according to the American Society of Echocardiography (ASE) and the European Assn. of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC). This expert consensus statement on the use of imaging to detect radiation-induced heart disease (RIHD) will be published in the September issue of the Journal of the American Society of Echocardiography (JASE). The writing group was co-chaired by Vuyisile Nkomo, M.D., an echocardiographer from the renowned Mayo Clinic in Rochester, Minn.

Home August 28, 2013
Home
Technology

AliveCor Inc. released a new AliveECG App for its Heart Monitor that features an Enhanced Filter, a noise cancelling technology that improves the visual output of the ECG. The AliveCor Heart Monitor is a mobile device-based ECG monitor for the iPhone 4, 4S and 5 that is used to record, display, store and transfer single-channel electrocardiogram (ECG) rhythms.

Home August 28, 2013
Home
News

Edwards Lifesciences Corp. announced that Japan's Central Social Insurance Medical Council (Chuikyo) has approved the recommendation by the Japanese Ministry of Health, Labor and Welfare's (MHLW) expert review panel to provide reimbursement for the Edwards Sapien XT transcatheter aortic heart valve. The reimbursement is scheduled to go into effect on Oct. 1.

Home August 27, 2013
Home
News

JenaValve Technology Inc. has successfully completed the first two implantations of its second-generation transapical JenaValve transcatheter aortic valve implantation (TAVI) system in Canada. These are also the first two implantations of the second-generation transapical JenaValve TAVI system outside of Europe.

Home August 26, 2013
Home
News

Adopting an approach that encourages continued progress while simultaneously acknowledging short-term obstacles, the Healthcare Information and Management Systems Society (HIMSS) recommends launching Stage 2 Meaningful Use on-schedule and extending Year 1 of the Meaningful Use Stage 2 attestation period through April 2015 and June 2015 for eligible hospitals (EHs) and eligible professionals (EPs), respectively. This would encompass 18 months in which EHs and EPs can attest to Meaningful Use requirements for one quarter.

Home August 26, 2013
Home
News

Boston Scientific Corp. has completed enrollment in the SuperNOVA trial – a global, single arm, prospective, multicenter clinical trial evaluating the long-term (12-month) safety and effectiveness of the Innova Self-Expanding Stent System (Innova Stent System). This stent system is designed for treating patients with a narrowing or blockage of the arteries above the knee, often associated with peripheral artery disease (PAD).

Home August 26, 2013
Home
News

Baptist Health eliminated 85 percent of CDs by storing and sharing medical images in real-time through Accelarad’s secure cloud platform. As central Alabama’s healthcare leader and one of only five Level II trauma facilities in the state, Baptist Health has been an Accelarad customer since March 2013.

Home August 23, 2013
Home
Subscribe Now